智能生物解决方案与IVY诊断公司合作,将药物筛查扩展到欧洲和中东。 Intelligent Bio Solutions partners with IVY Diagnostics to expand drug screening into Europe and the Middle East.

智能生物解决方案与IVY诊断公司合作,向欧洲和中东不断增长的毒品筛查市场扩展,到2030年,其价值分别为36亿美元和4.327亿美元。 Intelligent Bio Solutions has partnered with IVY Diagnostics to expand into Europe and the Middle East's growing drug screening markets, valued at $3.6 billion and $432.7 million by 2030, respectively. 伙伴关系的重点是药物康复和执法,包括与都灵警方一起进行指纹药物检测的试验。 The partnership focuses on drug rehabilitation and law enforcement, including a trial with the Turin police for fingerprint-based drug testing. 智能生物解决方案计划于2025年进入美国市场。 Intelligent Bio Solutions plans to enter the US market in 2025.